Go Backs
HomeCategoriesStatesCheck Your Home
Go Backs

Track product recalls and safety alerts from CPSC, FDA, NHTSA, and USDA. Stay informed and keep your family safe.

Browse

  • Categories
  • States
  • Check Your Home
  • Risk Levels

Agencies

  • CPSC
  • FDA Food
  • FDA Drug
  • FDA Device
  • FDA Veterinary
  • NHTSA
  • USDA

Company

  • About
  • FAQ
  • Contact
  • Terms of Service
  • Privacy Policy
Buy Me a Coffee

Recall data is sourced from official U.S. government agencies (CPSC, FDA, NHTSA, USDA) and processed using AI to improve readability. This site is not affiliated with or endorsed by any government agency. Always refer to the original agency notice for authoritative information.

ยฉ 2026 Go Backs. All rights reserved.

Medium RiskFDA Device
Medical Devices/Monitoring Devices

Fresenius Kabi USA, LLC: Ivenix Infusion System Software Recalled for Extended Start-up Delay

Agency Publication Date: September 25, 2023
Share:
Sign in to monitor this recall

Summary

Fresenius Kabi USA is recalling approximately 1,344 Ivenix Infusion System Large Volume Pumps running software versions 5.0.0 and 5.0.1. The recall was initiated because the pump's start-up time for certain flow rates (between 50 ml/hr and 200 ml/hr) can exceed the required 6-minute window. This delay occurs when air bubbles become trapped in the administration set's pumping chamber, which may lead to a significant delay in the delivery of critical fluids or medications to patients.

Risk

A delay in therapy initiation could result in the under-infusion of life-sustaining medications. Depending on the patient's condition and the medication being administered, this delay could cause serious health complications or the worsening of the condition being treated.

What You Should Do

  1. Identify if your facility is using the Ivenix Infusion System (IIS) Large Volume Pump (LVP) by checking for part number LVP-SW-0004.
  2. Verify the software version of your pump; this recall specifically affects Software Versions 5.0.0 and 5.0.1 with UDI 00811505030122.
  3. Immediately contact your healthcare provider or Fresenius Kabi USA to determine if your specific units require a software update or alternative mitigation steps.
  4. Report any adverse events or quality problems experienced with the use of this product to the FDA's MedWatch Adverse Event Reporting program.
  5. For further questions regarding this recall, contact Fresenius Kabi USA or the FDA at 1-888-463-6332 (1-888-INFO-FDA).

Your Remedy Options

๐Ÿ“‹Other Action

Manufacturer contact for guidance

How to: Contact your healthcare provider or the manufacturer for further instructions and potential refund

Affected Products

Product: Ivenix Infusion System (IIS), Large Volume Pump (LVP) Software Versions 5.0.0 and 5.0.1
Model / REF:
LVP-SW-0004
Z-2635-2023
Lot Numbers:
UDI: 00811505030122

Additional Information

Agency: Food and Drug Administration (FDA)
Event ID: 92973
Status: Active
Manufacturer: Fresenius Kabi USA, LLC
Sold By: hospitals; outpatient care environments
Manufactured In: United States
Units Affected: 1344 pumps
Distributed To: New Jersey, Wisconsin

Were You Affected by This Recall?

If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.

Find an Attorney

This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.

AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.

Sources: FDA iRES ยท Raw API Response

openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.